Ahmed Firoj, Ishibashi Masami
Graduate School of Pharmaceutical Sciences, Chiba University.
Chem Pharm Bull (Tokyo). 2016;64(2):119-27. doi: 10.1248/cpb.c15-00732.
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) has emerged as a promising anticancer agent as it selectively kills cancer cells. However, TRAIL resistance limits its use as a therapeutic agent. An understanding the mechanisms responsible for TRAIL resistance and strategies to overcome it are important for its effective use as an anticancer agent. During our studies to screen natural products from medicinal plants, we identified a number of compounds with synergistic effects on TRAIL-induced apoptosis in tumor cells. This review describes our recent studies on the isolation of bioactive compounds with TRAIL-resistance overcoming activity.
肿瘤坏死因子相关凋亡诱导配体(TRAIL)已成为一种有前景的抗癌药物,因为它能选择性地杀死癌细胞。然而,TRAIL耐药性限制了其作为治疗药物的应用。了解导致TRAIL耐药性的机制以及克服该耐药性的策略对于其有效用作抗癌药物至关重要。在我们从药用植物中筛选天然产物的研究过程中,我们鉴定出了一些对TRAIL诱导肿瘤细胞凋亡具有协同作用的化合物。这篇综述描述了我们最近关于分离具有克服TRAIL耐药活性的生物活性化合物的研究。